FDA grants real-time liver ablation AI clearance

The U.S. Food and Drug Administration gave De Novo clearance to Techsomed’s BioTraceIO, which leverages a computational algorithm to analyze ultrasound images captured during liver ablation treatment for use with its artificial intelligence-powered ablation treatment platform.

WHY IT MATTERS

Ablation treatment methods, like radiofrequency ablation, microwave ablation and cryoablation, are alternative first-line treatments for patients with…